ArticleBMC ophthalmology2025
Bilateral corneoscleritis with retrocorneal plaque as the initial presentation of granulomatosis with polyangiitis.
Article in BMC ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
backgroundTo report a case of bilateral corneoscleritis with retrocorneal plaque lesion as the presenting sign of granulomatous polyangiitis (GPA). CASE PRESENTATION: A 61-year-old female presented with bilateral extensive periphery corneoscleritis with retrocorneal plaque and prominent conjunctival injection. She suffered from progressively blurry vision and pain in both eyes for about 5 years, accompanied by sinusitis. No retinal or orbital abnormalities were noted on examination. A conjunctival and scleral biopsy was performed in the left eye, and the histopathological analysis was consistent with granulomatous inflammation. A full diagnostic workup revealed no obvious abnormal findings except positive cytoplasmic antineutrophil cytoplasmic antibody (cANCA) and proteinase 3-specific antineutrophil cytoplasmic antibody (PR3-ANCA). The patient achieved disease remission with cyclophosphamide and corticosteroid and remained on oral and topical medications with no further loss of vision or discomfort.
conclusionsThis is a unique documented case of corneoscleritis with retrocorneal plaque lesion as the initial presenting feature of GPA. Our case illustrates that the initial ocular manifestations of GPA involving the cornea and sclera may have atypical lesions. Clinicians should cautiously evaluate the patients to enhance the early diagnosis and promptly initiate treatment measures to prevent vision loss.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.